(19)
(11) EP 4 815 911 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24817062.3

(22) Date of filing: 20.11.2024
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 31/4422(2006.01)
A61P 9/12(2006.01)
 A61K 9/20(2006.01)
A61P 9/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4422; A61K 9/0056; A61K 9/2018; A61K 9/2054; A61K 9/2027; A61K 9/2013; A61K 9/2009; A61K 9/2095; A61P 9/12; A61P 9/10
 
C-Sets:
A61K 31/4422, A61K 2300/00;
(86) International application number:
PCT/EP2024/083012
(87) International publication number:
WO 2025/114117 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 GB 202318384

(71) Applicant: Novumgen Limited
London N1 7GU (GB)

(72) Inventor:
  • PATEL, Kamleshkumar
    London Greater London N1 7GU (GB)

(74) Representative: HGF 
HGF Limited 4th Floor, 1 City Square
Leeds LS1 2ES
Leeds LS1 2ES (GB)

   


(54) AN ORALLY DISINTEGRATING TABLET CONTAINING AMLODIPINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND THE PROCESS OF PREPARING THE SAME